Decoding mRNA stability: from endogenous decay pathways to therapeutic design
Nucleic Acid Insights · 02.06.2026 · 3 (4) · 227–231
DOI: 10.18609/nai.2026.029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acid Insights, online erschienen am 02.06.2026. Verfasst von Khalid SA Khabar. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
“...we need further work to expand our knowledge on mRNA‑protein interactomes across different tissue types or specific disease contexts...”Jokūbas Leikauskas, Editor, Nucleic Acid Insights , speaks to Khalid SA Khabar, Research Group Leader, King Faisal Specialist Hospital and Research Center, about how fundamental research into endogenous mRNA decay pathways, including AU‑rich elements, RNA‑binding proteins, and innate immune interactions, can inform the design and stabilization of therapeutic mRNAs.
Zitieren
APA
Khabar, K. S. (2026). Decoding mRNA stability: from endogenous decay pathways to therapeutic design. Nucleic Acid Insights, 3(4), 227–231. https://doi.org/10.18609/nai.2026.029
Vancouver
Khabar KS. Decoding mRNA stability: from endogenous decay pathways to therapeutic design. Nucleic Acid Insights. 2026;3(4):227–231. doi:10.18609/nai.2026.029
BibTeX
@article{Khabar2026,
author = {Khabar, Khalid SA},
title = {Decoding mRNA stability: from endogenous decay pathways to therapeutic design},
journal = {Nucleic Acid Insights},
year = {2026},
volume = {3},
number = {4},
pages = {227–231},
doi = {10.18609/nai.2026.029}
}
EUVIMED